370 related articles for article (PubMed ID: 27724908)
1. Cost-effectiveness analysis of microscopic observation drug susceptibility test versus Xpert MTB/Rif test for diagnosis of pulmonary tuberculosis in HIV patients in Uganda.
Walusimbi S; Kwesiga B; Rodrigues R; Haile M; de Costa A; Bogg L; Katamba A
BMC Health Serv Res; 2016 Oct; 16(1):563. PubMed ID: 27724908
[TBL] [Abstract][Full Text] [Related]
2. Microscopic observation drug-susceptibility assay vs. Xpert
Wikman-Jorgensen PE; Llenas-García J; Pérez-Porcuna TM; Hobbins M; Ehmer J; Mussa MA; Ascaso C
Trop Med Int Health; 2017 Jun; 22(6):734-743. PubMed ID: 28380276
[TBL] [Abstract][Full Text] [Related]
3. Cost Analysis of Tuberculosis Diagnosis in Cambodia with and without Xpert
Pallas SW; Courey M; Hy C; Killam WP; Warren D; Moore B
Appl Health Econ Health Policy; 2018 Aug; 16(4):537-548. PubMed ID: 29862440
[TBL] [Abstract][Full Text] [Related]
4. Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation.
Menzies NA; Cohen T; Lin HH; Murray M; Salomon JA
PLoS Med; 2012; 9(11):e1001347. PubMed ID: 23185139
[TBL] [Abstract][Full Text] [Related]
5. Modeling the patient and health system impacts of alternative xpert® MTB/RIF algorithms for the diagnosis of pulmonary tuberculosis in Addis Ababa, Ethiopia.
Tesfaye A; Fiseha D; Assefa D; Klinkenberg E; Balanco S; Langley I
BMC Infect Dis; 2017 May; 17(1):318. PubMed ID: 28464797
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Xpert MTB/RIF and MODS assay for the diagnosis of pediatric tuberculosis.
Nhu NT; Ha DT; Anh ND; Thu DD; Duong TN; Quang ND; Lan NT; Quyet TV; Tuyen NT; Ha VT; Giang DC; Dung NH; Wolbers M; Farrar J; Caws M
BMC Infect Dis; 2013 Jan; 13():31. PubMed ID: 23343418
[TBL] [Abstract][Full Text] [Related]
8. Systematic review: Comparison of Xpert MTB/RIF, LAMP and SAT methods for the diagnosis of pulmonary tuberculosis.
Yan L; Xiao H; Zhang Q
Tuberculosis (Edinb); 2016 Jan; 96():75-86. PubMed ID: 26786658
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Xpert® MTB/RIF assay and microscopy for the diagnosis of Mycobacterium tuberculosis in Namibia.
Mavenyengwa RT; Shaduka E; Maposa I
Infect Dis Poverty; 2017 Jan; 6(1):13. PubMed ID: 28086955
[TBL] [Abstract][Full Text] [Related]
10. Xpert MTB/RIF test for tuberculosis.
Ferrara G; O'Grady J; Zumla A; Maeurer M
Lancet; 2011 Aug; 378(9790):482; author reply 482-3. PubMed ID: 21821179
[No Abstract] [Full Text] [Related]
11. Meta-analysis to compare the accuracy of GeneXpert, MODS and the WHO 2007 algorithm for diagnosis of smear-negative pulmonary tuberculosis.
Walusimbi S; Bwanga F; De Costa A; Haile M; Joloba M; Hoffner S
BMC Infect Dis; 2013 Oct; 13():507. PubMed ID: 24172543
[TBL] [Abstract][Full Text] [Related]
12. Cost-benefit analysis of Xpert MTB/RIF for tuberculosis suspects in German hospitals.
Diel R; Nienhaus A; Hillemann D; Richter E
Eur Respir J; 2016 Feb; 47(2):575-87. PubMed ID: 26647440
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of the Xpert® MTB/RIF assay for tuberculosis diagnosis in Brazil.
Pinto M; Steffen RE; Cobelens F; van den Hof S; Entringer A; Trajman A
Int J Tuberc Lung Dis; 2016 May; 20(5):611-8. PubMed ID: 27084814
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of the new Xpert MTB/RIF Ultra for tuberculosis disease: A preliminary systematic review and meta-analysis.
Zhang M; Xue M; He JQ
Int J Infect Dis; 2020 Jan; 90():35-45. PubMed ID: 31546008
[TBL] [Abstract][Full Text] [Related]
15. [Incremental cost-effectiveness of the second Xpert MTB/RIF assay for detection of Mycobacterium tuberculosis].
Wang SQ; Sun Q; Jiang GL; Fu YY; Shang YY; Huang HR; Wang GR
Zhonghua Jie He He Hu Xi Za Zhi; 2019 Jun; 42(6):432-437. PubMed ID: 31189229
[No Abstract] [Full Text] [Related]
16. Estimated clinical impact of the Xpert MTB/RIF Ultra cartridge for diagnosis of pulmonary tuberculosis: A modeling study.
Kendall EA; Schumacher SG; Denkinger CM; Dowdy DW
PLoS Med; 2017 Dec; 14(12):e1002472. PubMed ID: 29240766
[TBL] [Abstract][Full Text] [Related]
17. Performance of the Xpert MTB/RIF assay in the diagnosis of tuberculosis in formalin-fixed, paraffin-embedded tissues.
Polepole P; Kabwe M; Kasonde M; Tembo J; Shibemba A; O'Grady J; Kapata N; Zumla A; Bates M
Int J Mycobacteriol; 2017; 6(1):87-93. PubMed ID: 28317811
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of different Xpert MTB/Rif implementation strategies in programmatic settings at the regional referral hospitals in Uganda: Evidence for country wide roll out.
Muttamba W; Ssengooba W; Sekibira R; Kirenga B; Katamba A; Joloba M
PLoS One; 2018; 13(3):e0194741. PubMed ID: 29566056
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of novel algorithms for rapid diagnosis of tuberculosis in HIV-infected individuals in Uganda.
Shah M; Dowdy D; Joloba M; Ssengooba W; Manabe YC; Ellner J; Dorman SE
AIDS; 2013 Nov; 27(18):2883-92. PubMed ID: 25119690
[TBL] [Abstract][Full Text] [Related]
20. Bacteriological diagnosis of childhood TB: a prospective observational study.
Brent AJ; Mugo D; Musyimi R; Mutiso A; Morpeth SC; Levin M; Scott JAG
Sci Rep; 2017 Sep; 7(1):11808. PubMed ID: 28924198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
